Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis

NCT00207688 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT00207688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
August 31, 2004
Completion date
September 9, 2015
Enrollment
505 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis